A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and nutritional ingredients

picture of

Breaking News

Developing novel antibody therapeutics

ProBioGen and Pionyr Immunotherapeutics initiate a second immuno-oncology contract development and manufacturing project

WuXi Biologics initiate construction of integrated ADC solution center

Offering end-to-end solutions for biologic products the company has started building the facility in Wuxi city in China

ADCs need more efficient manufacturing processes

Welsh ADC Biotechnology, a company working to simplify and lower production costs for anti-cancer blockbuster drugs, ...

Improving reproducibility in translational medicine

In translational medicine, wherein bringing tools such as diagnostic biomarkers from bench to bedside is a main focus, ...

Zai Lab and Crescendo Biologics enter exclusive global license agreement

Agreement will develop, commercialise and manufacture a topical, innovative antibody VH domain therapeutic for ...

BBI Solutions expands infectious disease reagent suite

BBI Solutions has demonstrated internal antibody development capabilities and has also expanded its infectious disease ...

Collaboration to identify antibodies for cancer targets

Iontas and IGEM Therapeutics will work together to develop novel immunoglobulin E antibodoes

AbbVie and Eisai obtain additional approval for Humira

The monoclonal antibody, Humira, is used in the treatment of patients who have had an inadequate response to ...

The future of uniquely delivered drugs and ADCs

Kruthika Dhar of Thatís Nice reports on unique delivery drugs and the marketplace

New facility for biopharmaceutical manufacturing in China

United BioPharma plans to build a state-of-the-art manufacturing plant to support the expanding monoclonal antibody ...

Iontas to generate antibodies using mammalian display technology

Iontas to generate antibodies with favourable, binding and expression properties using its mammalian display antibody ...